Advertisement


Allison J. Applebaum, PhD, and William S. Breitbart, MD, on Adapting Meaning-Centered Psychotherapy for Caregivers

2015 IPOS APOS World Congress of Psycho-Oncology

Advertisement

Allison J. Applebaum, PhD, and William S. Breitbart, MD, of Memorial Sloan Kettering Cancer Center, explain how they brought this new treatment to help stressed caregivers of loved ones with cancer.



Related Videos

Supportive Care

Allison J. Applebaum, PhD, and William S. Breitbart, MD, on Workshops in Meaning-Centered Psychotherapy

Allison J. Applebaum, PhD, and William S. Breitbart, MD, of Memorial Sloan Kettering Cancer Center, discuss a meaning-centered psychotherapy workshop they conducted for an international group of clinicians.

Palliative Care

Wendy Lichtenthal, PhD, and David Kissane, MD, on Models of Family-Centered Care During Palliative Care and Bereavement

Wendy Lichtenthal, PhD, of Memorial Sloan Kettering Cancer Center, and David Kissane, MD, of Monash University, discuss the importance of and challenges with attending to the whole family during palliative care.

Supportive Care
Issues in Oncology
Survivorship

Lori Wiener, PhD, DCSW, LCSW-C, and Karen Fasciano, PsyD, on Psycho-Oncology: Where the Field Is Headed

Lori Wiener, PhD, DCSW, LCSW-C, of the National Cancer Institute, and Karen Fasciano, PsyD, of the Dana-Farber Cancer Institute, discuss the challenges of the art and science of psycho-oncology.

Supportive Care

Patricia A. Ganz, MD, on Incorporating Psychosocial Services for Quality Cancer Care

Patricia A. Ganz, MD, of the University of California, Los Angeles, discusses the Institute of Medicine report on patient-centered care, its relation to psychosocial services, and the role IPOS/APOS members can play.

Survivorship
Supportive Care
Prostate Cancer

Christopher J. Recklitis, PhD, MPH, on The Risk of Suicide After a Cancer Diagnosis

Christopher J. Recklitis, PhD, MPH, of the Dana-Farber Cancer Institute, discusses what is known about suicide after cancer, the risks faced by prostate cancer patients within the first year after diagnosis, and challenges across the treatment trajectory

Advertisement

Advertisement




Advertisement